Harrow (HROW) Receivables (2014 - 2026)
Harrow (HROW) recorded quarterly Receivables of $101.3 million in Q1 2026, down 8.69% quarter-over-quarter from $110.9 million in Q4 2025, and up 31.4% on a YoY basis from $77.1 million in Q1 2025.
Harrow (HROW) Receivables (2014 - 2026) Analysis & Trends
Harrow's Receivables history runs 13 years deep, the most recent figure standing at $101.3 million for Q1 2026.
- In Q1 2026, Receivables rose 31.4% year-over-year to $101.3 million; the TTM figure through Mar 2026 stood at $101.3 million (up 31.4% YoY), while the FY2025 annual figure was $110.9 million, down 4.71% from the prior year.
- Receivables was $101.3 million for Q1 2026 at Harrow, down from $110.9 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $116.4 million in Q4 2024 to a low of $918000.0 in Q4 2022.
- Historically, Receivables has averaged $46.3 million across 5 years, with a median of $29.0 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Receivables soared 1903.81% in 2023, then retreated 4.71% in 2025.
- A 5-year view of Receivables shows it stood at $918000.0 in 2022, then jumped by 1903.81% to $18.4 million in 2023, then jumped by 532.63% to $116.4 million in 2024, then slipped by 4.71% to $110.9 million in 2025, then decreased by 8.69% to $101.3 million in 2026.
- The last three Receivables figures came in at $101.3 million (Q1 2026), $110.9 million (Q4 2025), and $77.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 3.39 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.51 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 312.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 31.29 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 768.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 1.15 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 407.63 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 149.62 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 355.67 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn | 101.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 101.26 Mn |
| Dec 31, 2025 | 110.90 Mn |
| Sep 30, 2025 | 77.60 Mn |
| Jun 30, 2025 | 78.82 Mn |
| Mar 31, 2025 | 77.06 Mn |
| Dec 31, 2024 | 116.37 Mn |
| Sep 30, 2024 | 53.73 Mn |
| Jun 30, 2024 | 52.73 Mn |
| Mar 31, 2024 | 28.96 Mn |
| Dec 31, 2023 | 18.40 Mn |
| Sep 30, 2023 | 18.70 Mn |
| Jun 30, 2023 | 18.99 Mn |
| Mar 31, 2023 | 12.31 Mn |
| Dec 31, 2022 | 918,000.00 |
| Sep 30, 2022 | 6.88 Mn |
| Jun 30, 2022 | 6.86 Mn |
| Mar 31, 2022 | 6.07 Mn |
| Dec 31, 2021 | 88,000.00 |
| Sep 30, 2021 | 4.17 Mn |
| Jun 30, 2021 | 4.60 Mn |